Home

PharmaVentures

Unrivalled global expertise in pharma M&A and licensing
  • Twitter
  • Linkedin

Search form

  • Home
  • About Us
    • Vision, Mission & Values
    • Our Team
    • Testimonials
    • Our Successes
  • Services
    • M&A and Divestments
    • Licensing
    • Strategy & Valuation
    • Expert Services
    • Workshops
  • Clients
    • Clients
    • Case Studies
    • Project Canella 2
    • Project Canella
    • Project Romeo
  • Our News
    • Press Releases
    • Blog Articles
    • Case Studies
    • Termsheet
    • White Papers
    • PharmaVentures InSights: The impact of conference cancellations on dealmaking during the Covid-19 pandemic
    • PharmaVentures InSights: Doing deals in the healthcare sector during the Covid-19 pandemic
    • PharmaVentures InSights: Korea Special
    • PharmaTelevision
  • Register
    • Newsletter
  • Contact Us
  • Careers
PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor
Due diligence, expert testimony and dispute resolution Valuation, bench marking and strategy Business development services: in-licensing and out-licensing Sell side and buy side advisory, deal structuring and negotiation support
M&A
Sellside Advisor
2018
M&A
Sellside Advisor
2018
M&A
Buyside Advisor
2018
FundRaising
Sellside Advisor
2017
Divestment
Sellside Advisor
2016
Licensing
Buyside Advisor
2016
M&A
Buyside Advisor
2016
Divestment
Sellside Advisor
2016
M&A
Sellside Advisor
2015
M&A
Sellside Advisor
2015
M&A
Buyside Advisor
2015
M&A
Sellside Advisor
2015
Licensing
Sellside Advisor
2014
Licensing
Sellside Advisor
2014
M&A
Sellside Advisor
2014
M&A
Sellside Advisor
2014
M&A
Sellside Advisor
2013
M&A
Sellside Advisor
2013
M&A
Sellside Advisor
2013
M&A
Sellside Advisor
2012
Licensing
Sellside Advisor
2011
M&A
Sellside Advisor
2011
Licensing
Buyside Advisor
2011
M&A
Sellside Advisor
2011
Licensing
Buyside Advisor
2010
Previous Pause Next

Global expertise in M&A, partnering and fund-raising

We have a successful track record in transaction outcomes in M&A, partnering and fund-raising. Our expertise brings a unique; strategic and commercial insight within healthcare. This makes us ideally placed to support your business from strategic development, through to valuation/deal terms and, ultimately, to getting your deal done.

We offer a comprehensive range of deal related healthcare advisory services and we are trusted to deliver quality results to our clients. Our clients range from blue-chip corporations to small start-up innovator entities across the globe. Our coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. We are are also active in the CRO and CMO M&A. See what our clients say here.

Our experience of nearly 30 years is gained from working with clients' in 38 countries and conducting more than 1,000 assignments. Regulated work is conducted through PharmaVentures Capital Ltd, a wholly owned subsidiary of PharmaVentures Ltd, that is authorised and regulated by the UK Financial Conduct Authority. FRN: 741356

Contact PharmaVentures

Information & Insights

Contact Us

Address:
Triumph House | Parkway Court | John Smith Drive |

Oxford Business Park | Oxford | OX4 2JY

Phone: +44 (0) 1865 332 700

Email: enquiries@pharmaventures.com

  • Twitter
  • Linkedin

© Copyright 1992 - 2020 by PharmaVentures Ltd. All Rights Reserved.

T&C I Anti-Bribery Statement I Disclaimer I Privacy I Contact I Site Map